GLS and hepatocellular carcinoma: Taken together, Gln metabolism can increase the stemness properties in HCC through activating ROS/Wnt/β-catenin pathway, and targeting Gln metabolism, especially GLS1, may be a therapeutic target for the elimination of CSCs.